Volume 23 (2020)
Volume 22 (2019)
Volume 21 (2018)
Volume 20 (2017)
Volume 19 (2016)
Volume 18 (2015)
Volume 17 (2014)
Volume 16 (2013)
Volume 15 (2012)
Volume 14 (2011)
Volume 13 (2010)
Volume 12 (2009)
Volume 11 (2008)
Volume 10 (2007)
Volume 9 (2006)
Volume 8 (2005)
Volume 7 (2004)
Volume 6 (2002)
Volume 5 (2002)
Volume 4 (2000)
Volume 3 (1999)
Volume 2 (1998)
Volume 1 (1997)
1. Basic data of patients with skin drug reactions admitted to Razi Hospital, Tehran, Iran

Ehsani Amirhoushang; Mortazavi Hossein; Azizpour Arghavan; Ansari Mahsa; Teimori Edris; Goodarzi Azadeh; Rahbar Ziba; Aryanian Zeinab

Volume 17, Issue 2 , 2014, , Pages 63-67

Abstract
  Background: Although most cases of drug eruptions are mildand self-limited and are relieved after discontinuation of theresponsible drugs, statistics of life threatening outcomes shouldbe kept in mind. Moreover, it is important to identify the mostcommon age and sex groups, and the most vulnerable groupsin ...  Read More

2. Creatine phosphokinase values and myalgia during isotretinoin therapy

Ghiasi Maryam; Lajevardi Vahide; Mortazavi Hossein; Damavandi Maedeh Raiyati

Volume 16, Issue 4 , 2013, , Pages 137-140

Abstract
  Background: Systemic isotretinoin is a very effective medication for the treatment of acne, but it has some side effects. One of its side effects is musculoskeletal problems such as increased levels of creatine phosphokinase (CPK), myalgia, and serious muscle damage such as rhabdomyolysis. The aim of ...  Read More

3. A review of three systemic retinoids in dermatology: acitretin, isotretinoin and bexarotene

Mortazavi Hossein; Aghazadeh Nessa; Ghiasi Maryam; Lajevardi Vahideh

Volume 16, Issue 4 , 2013, , Pages 144-158

Abstract
  Retinoids are synthetic and natural analogues of vitamin A that have various effects on cellular differentiation, cellular proliferation, immune system, and embryonic development. The present study reviews the history of systemic retinoids in medicine, the structure of syn  Read More

5. Successful treatment of major pemphigus vulgaris relapse with mycophenolate mofetil and high-potent topical corticosteroid

Esmaili Nafiseh; Chams-Davatchi Cheyda; Daneshpazhooh Maryam; Ghiasi Maryam; Abedini Robabe; Mortazavi Hossein; Roghani Iman

Volume 15, Issue 2 , 2012, , Pages 33-37

Abstract
  Background: Pemphigus vulgaris (PV) is an autoimmune bullous disorder that is fatal if left untreated. High dose systemic corticosteroids are the basis of therapy. The addition of immunosuppressive agents has improved the disease outcome and reduced the required corticosteroid dose and related toxicity. ...  Read More

6. The Influence of Treatment of Pemphigus Vulgaris on the Serum Level of Cytokines

Mortazavi Hossein; Amirzargar Ali Akbar; Valikhani Mahin; Hallaji Zahra; Daneshpazhouh Maryam; Tabrizi Mohammad Javad Nazemi; Seirafi Hassan; Nikbin Behrouz; Khosravi Farideh; Toosi Siyavash; Chams-Davatchi Cheida

Volume 11, Issue 1 , 2008, , Pages 11-16

Abstract
  Background: In addition to humoral immunity associated with anti-desmoglein antibodies, cellular immunity and mediators including cytokines are involved in the pathogenesis of pemphigus vulgaris. In this study we evaluated the level of IL-2, IFN-γ, TNF-α, IL-4, and IL-10 in the sera of patients ...  Read More